Salahadin Abdi
Overview
Explore the profile of Salahadin Abdi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
2514
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Benzon H, Provenzano D, Nagpal A, Souza D, Eckmann M, Nelson A, et al.
Reg Anesth Pain Med
. 2025 Feb;
PMID: 40015722
Background: Intra-articular corticosteroid (IACS) injection and peri-articular corticosteroid injection are commonly used to treat musculoskeletal conditions. Results vary by musculoskeletal region, but most studies report short-term benefit with mixed results...
2.
Vu P, Abdi S
Pain Manag
. 2025 Feb;
15(3):119-122.
PMID: 39988804
Management of neuropathic corneal pain (NCP) typically involves pharmacotherapy, but refractory cases may require interventions like scrambler therapy, used for various neuropathic pain conditions. We report a patient with a...
3.
Hirani S, Benkli B, Odonkor C, Hirani Z, Oso T, Bohacek S, et al.
J Pain Res
. 2024 Nov;
17:3639-3649.
PMID: 39529944
Background: This meta-analysis is an update to a seminal meta-analysis on racial/ethnic disparities in pain treatment in the United States (US) published in 2012. Since then, literature has accumulated on...
4.
Wahezi S, Zar S, Oakes D, Naeimi T, Yerra S, Downie S, et al.
Ann Transl Med
. 2024 Nov;
12(5):85.
PMID: 39507457
Background: This manuscript presents the challenges of treating various forms of headaches and the potential of interventional techniques targeting the greater occipital nerve (GON) to alleviate the burden on patients....
5.
Vu P, Abdi S
A A Pract
. 2024 Oct;
18(8):e01834.
PMID: 39440951
Among the 2 million amputees in the United States, 60% to 90% will experience phantom limb pain (PLP). Managing PLP presents challenges with current evidence-based pharmacological and interventional therapies yielding...
6.
Yoon S, Huh B, Abdi S, Javed S
Lasers Med Sci
. 2024 Aug;
39(1):208.
PMID: 39096352
High-intensity laser therapy (HILT) has recently been incorporated into wound management therapeutic protocols (Mosca RC et al. (2019) Photobiomodulation Therapy for Wound Care: A Potent, Noninvasive, Photoceutical Approach. Adv Skin...
7.
Benzon H, Elmofty D, Shankar H, Rana M, Chadwick A, Shah S, et al.
Reg Anesth Pain Med
. 2024 Jul;
PMID: 39019502
Background: There is potential for adverse events from corticosteroid injections, including increase in blood glucose, decrease in bone mineral density and suppression of the hypothalamic-pituitary axis. Published studies note that...
8.
Chung M, Chen T, Wang X, Kim K, Abdi S
Pain Pract
. 2024 Feb;
24(5):749-759.
PMID: 38418433
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating disturbance among patients who received chemotherapy, with no effective treatment available. Scrambler therapy (ST) is a noninvasive treatment capable of improving multiple...
9.
Manchikanti L, Knezevic E, Knezevic N, Sanapati M, Kaye A, Abdi S, et al.
Pain Physician
. 2024 Feb;
27(2):E169-E206.
PMID: 38324785
Background: Chronic axial spinal pain is one of the major causes of disability. Literature shows that spending on low back and neck pain and musculoskeletal disorders continues to escalate, not...
10.
Kim H, Wang Q, Hwang S, Dougherty P, Wang J, Abdi S
Anesth Analg
. 2023 Dec;
138(3):664-675.
PMID: 38112490
Background: Many chemotherapeutic drugs, including paclitaxel, produce neuropathic pain in patients with cancer, which is a dose-dependent adverse effect. Such chemotherapy-induced neuropathic pain (CINP) is difficult to treat with existing...